ES
55
2
C
55
-2
DAL
77
-7
MU
31
-4
SCHW
50
-2
HST
45
-7
MKC
53
2
T
45
4
CI
45
-5
AMGN
41
3
GM
72
6
YUM
36
-3
MSFT
46
-11
F
39
-8
ADT
48
-3
PFG
37
-3
GME
54
-5
AN
41
-2
WBA
51
4
EMR
48
-2
ES
55
2
C
55
-2
DAL
77
-7
MU
31
-4
SCHW
50
-2
HST
45
-7
MKC
53
2
T
45
4
CI
45
-5
AMGN
41
3
GM
72
6
YUM
36
-3
MSFT
46
-11
F
39
-8
ADT
48
-3
PFG
37
-3
GME
54
-5
AN
41
-2
WBA
51
4
EMR
48
-2
Financhill
Back

Aprea Therapeutics 10K Form

Sell
4

APRE
Aprea Therapeutics

Last Price:
3.94
Seasonality Move:
-10.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive APRE News And Ratings

See the #1 stock for the next 7 days that we like better than APRE

APRE Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-3.65M
Price / Cash Flow: 0
Annual Sales: $4.71
Price / Book: 0.83

Profitability

EPS (TTM): -3.03000
Net Income (TTM): $-12.93M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Aprea Therapeutics Earnings Forecast

Key Aprea Therapeutics Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

Aprea Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: APRE
CUSIP: 03836J
Website: aprea.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

APRE Technical Analysis vs Fundamental Analysis

Sell
4
Aprea Therapeutics (APRE) is a Sell

Is Aprea Therapeutics a Buy or a Sell?